ATE195937T1 - Pyridazinone-derivate und verfahren zur deren herstellung - Google Patents

Pyridazinone-derivate und verfahren zur deren herstellung

Info

Publication number
ATE195937T1
ATE195937T1 AT96110412T AT96110412T ATE195937T1 AT E195937 T1 ATE195937 T1 AT E195937T1 AT 96110412 T AT96110412 T AT 96110412T AT 96110412 T AT96110412 T AT 96110412T AT E195937 T1 ATE195937 T1 AT E195937T1
Authority
AT
Austria
Prior art keywords
production
pyridazinone derivatives
pyridazinone
derivatives
Prior art date
Application number
AT96110412T
Other languages
English (en)
Inventor
Akihiko Ishida
Harutami Yamada
Michihisa Yato
Shinsuke Nishiyama
Fumikazu Okumura
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE195937T1 publication Critical patent/ATE195937T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Couplings Of Light Guides (AREA)
AT96110412T 1995-06-27 1996-06-27 Pyridazinone-derivate und verfahren zur deren herstellung ATE195937T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16062095 1995-06-27
JP1985996 1996-02-06

Publications (1)

Publication Number Publication Date
ATE195937T1 true ATE195937T1 (de) 2000-09-15

Family

ID=26356726

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96110412T ATE195937T1 (de) 1995-06-27 1996-06-27 Pyridazinone-derivate und verfahren zur deren herstellung

Country Status (21)

Country Link
US (2) US5698554A (de)
EP (1) EP0751132B1 (de)
KR (1) KR970061873A (de)
CN (1) CN1144802A (de)
AR (1) AR002602A1 (de)
AT (1) ATE195937T1 (de)
AU (1) AU694955B2 (de)
BG (1) BG62768B1 (de)
CA (1) CA2179939A1 (de)
DE (1) DE69610036T2 (de)
DK (1) DK0751132T3 (de)
ES (1) ES2151110T3 (de)
GR (1) GR3034910T3 (de)
HU (1) HUP9601766A3 (de)
IL (1) IL118631A (de)
MY (1) MY132263A (de)
NO (1) NO311084B1 (de)
PT (1) PT751132E (de)
RU (1) RU2131419C1 (de)
SG (1) SG46741A1 (de)
TW (1) TW432052B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2424551A1 (en) * 1997-05-27 1998-11-27 Schneider (Usa) Inc. Stent and stent-graft for treating branched vessels
AR025752A1 (es) * 1999-09-28 2002-12-11 Bayer Corp Piridinas y piridacinas sustituidas con actividad de inhibicion de angiogenesis
KR20030061051A (ko) * 2002-01-07 2003-07-18 대한민국 (경상대학교 총장) 신규한 아렌(혹은 알케인)술폰일피리다진온 유도체, 이의제조방법 및 유기반응에서의 용도
AR050552A1 (es) * 2004-09-02 2006-11-01 Osi Pharm Inc Mercaptoamidas como inhibidores de histona desacetilasa
ZA200807796B (en) * 2006-03-17 2009-12-30 Sumitomo Chemical Co Pyridazinone compound and use thereof as herbicides
EP2502918B1 (de) * 2006-07-25 2015-03-25 Cephalon, Inc. Pyridiazinon-Derivate
JP5758630B2 (ja) * 2007-11-15 2015-08-05 エンメエッセディ・イタリア・エッセ・エッレ・エッレ Parp阻害剤としてのピリダジノン誘導体
WO2011116287A1 (en) * 2010-03-19 2011-09-22 Purdue Research Foundation Ccr5 modulators for treating hiv
CN103201279A (zh) 2010-11-05 2013-07-10 赛诺米克斯公司 作为trpm8的调节剂有用的化合物
EP2723718A1 (de) 2011-06-24 2014-04-30 Amgen Inc. Trpm8-antagonisten und ihre verwendung bei behandlungen
AP2013007331A0 (en) 2011-06-24 2013-12-31 Amgen Inc TRPM8 antagonists and their use in treatments
WO2013097052A1 (en) 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
BR112018006471B1 (pt) 2015-10-01 2024-02-27 Senomyx, Inc Composto, composição, método de modular o membro de melastina do canal potencial do receptor transitório 8 (trpm8), método de modular a sensação de resfrescância de uma composição e método de induzir uma sensação de refrescância em um ser humano ou animal
AU2017251537B2 (en) 2016-04-15 2020-10-08 Abbvie Inc. Bromodomain inhibitors
EP3873474A4 (de) * 2018-10-30 2022-07-13 Nuvation Bio Inc. Heterocyclische verbindungen als bet-hemmer
KR102885525B1 (ko) 2018-11-06 2025-11-13 엣지와이즈 테라퓨틱스, 인크. 피리다지논 화합물 및 이의 용도
SMT202300355T1 (it) 2018-11-06 2024-01-10 Edgewise Therapeutics Inc Composti di piridazinone e loro usi
WO2020097258A1 (en) 2018-11-06 2020-05-14 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof
JP7465945B2 (ja) 2019-07-02 2024-04-11 ニューベイション・バイオ・インコーポレイテッド Bet阻害剤としてのヘテロ環式化合物
EP4473968A3 (de) 2020-05-13 2025-03-26 Edgewise Therapeutics, Inc. Pyridazinonverbindungen und verwendungen davon

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6053022B2 (ja) * 1977-04-07 1985-11-22 ウェルファイド株式会社 ピリダジノン誘導体
GB8323553D0 (en) * 1983-09-02 1983-10-05 Smith Kline French Lab Pharmaceutical compositions
JPS6193169A (ja) * 1984-10-12 1986-05-12 Sankyo Co Ltd ピリダジノン誘導体及びその製法
KR860007219A (ko) * 1985-03-12 1986-10-08 베쩰, 좀머 설포닐아미노에틸 화합물의 제조방법
DE3508692A1 (de) 1985-03-12 1986-09-18 Dr. Karl Thomae Gmbh, 7950 Biberach 3-(4-(2-benzolsulfonylamino-aethyl)-benzoyl)propionsaeure, diese verbindung enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0194548A3 (de) * 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
JPS63145272A (ja) * 1986-12-09 1988-06-17 Morishita Seiyaku Kk 4,5−ジヒドロ−6−(4−置換フエニル)−3(2h)−ピリダジノン誘導体
SU1486061A3 (ru) * 1987-03-26 1989-06-07 Mitsubishi Chem Ind Способ получения производных пиридазинона или их солей
DE3728491A1 (de) * 1987-08-26 1989-03-09 Heumann Pharma Gmbh & Co Dihydropyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4134467A1 (de) * 1991-10-18 1993-04-22 Thomae Gmbh Dr K Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
AU651182B2 (en) * 1991-03-01 1994-07-14 Zeria Pharmaceutical Co., Ltd. Indan derivative and thromboxane antagonist containing the same
CA2099743A1 (en) * 1992-07-02 1994-01-03 Akihiko Ishida Pyridazinone derivatives and processes for preparing the same
JP2616584B2 (ja) * 1992-07-02 1997-06-04 田辺製薬株式会社 ピリダジノン誘導体及びその製法
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same
JP2757353B2 (ja) * 1993-12-28 1998-05-25 田辺製薬株式会社 インダン誘導体、その製法及びその合成中間体
CA2139088A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivatives, processes for preparing the same and synthetic intermediate of the same

Also Published As

Publication number Publication date
CA2179939A1 (en) 1996-12-28
DK0751132T3 (da) 2000-11-13
GR3034910T3 (en) 2001-02-28
AU694955B2 (en) 1998-08-06
ES2151110T3 (es) 2000-12-16
PT751132E (pt) 2000-12-29
HUP9601766A2 (en) 1997-02-28
NO962643D0 (no) 1996-06-21
IL118631A (en) 2002-05-23
BG100684A (bg) 1997-03-31
AU5622196A (en) 1997-01-09
EP0751132B1 (de) 2000-08-30
TW432052B (en) 2001-05-01
KR970061873A (ko) 1997-09-12
MY132263A (en) 2007-09-28
SG46741A1 (en) 1998-02-20
DE69610036T2 (de) 2001-04-12
HUP9601766A3 (en) 1998-04-28
DE69610036D1 (de) 2000-10-05
NO962643L (no) 1996-12-30
BG62768B1 (bg) 2000-07-31
US5808065A (en) 1998-09-15
EP0751132A1 (de) 1997-01-02
IL118631A0 (en) 1996-10-16
AR002602A1 (es) 1998-03-25
US5698554A (en) 1997-12-16
NO311084B1 (no) 2001-10-08
RU2131419C1 (ru) 1999-06-10
HU9601766D0 (en) 1996-08-28
CN1144802A (zh) 1997-03-12

Similar Documents

Publication Publication Date Title
DE59404480D1 (de) Fullerenderivate, verfahren zur herstellung und deren verwendung
DE69532895D1 (de) Biomaterial und verfahren zu dessen herstellung
DE69530312D1 (de) Stabiles lycopin konzentrat und verfahren zu seiner herstellung
DE69941054D1 (de) Isosorbid enthaltende poyester und verfahren zu deren herstellung
DE69623926D1 (de) Kugelgelenk und verfahren zur herstellung
DE69635345D1 (de) Kautschukzusammensetzung und verfahren zu deren herstellung
DE69535720D1 (de) Faserstoffbahn und verfahren zur dessen herstellung
DE69610226D1 (de) Adsorptionsmedium und verfahren zur dessen herstellung
DE69528111D1 (de) Biosensor und Verfahren zur Herstellung desselben
DE69804217D1 (de) Dekorfolie und verfahren zu deren herstellung
DE69630732D1 (de) Mehrzelliges Dämpfungselement und Verfahren zur dessen Herstellung
DE69511714D1 (de) Fahrzeugfenster und verfahren zu dessen herstellung
DE69616516D1 (de) Wasserschutzzusammensetzungen und verfahren zu deren herstellung
DE69715661D1 (de) Verfahren und anlage zur herstellung von methanol
DE69530954D1 (de) Mikromechanisches Bauelement und Verfahren zur Herstellung desselben
DE69710484D1 (de) Übergezogene süsswaren und verfahren zu deren herstellung
DE69815126D1 (de) Pyrimidinderivate und verfahren zu deren herstellung
DE19681517T1 (de) Dekorationsfolie und Verfahren zur Herstellung derselben
DE59603734D1 (de) Integrales plattenförmiges bauteil und verfahren zu seiner herstellung
DE69519739D1 (de) Epdm zusammensetzungen und verfahren zur herstellung davon
ATE262532T1 (de) Substituierte camptothecinderivate und verfahren zur ihrer herstellung
DE69610036D1 (de) Pyridazinone-Derivate und Verfahren zur deren Herstellung
DE69608359D1 (de) Hexaazaisowurtzitan-derivate und verfahren zu deren herstellung
DE69402688D1 (de) Luftfilter und verfahren zu seiner herstellung
DE69503332D1 (de) Gleitstück und verfahren zu dessen herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee